The alpha-7 nicotinic acetylcholine receptor (α7nAChR) is a ligand-gated ion channel expressed on immune cells (macrophages, dendritic cells, T cells) and neurons that mediates the cholinergic anti-inflammatory pathway, providing a direct neural mechanism to suppress inflammation via vagal efferent signaling.
When activated by acetylcholine (from vagal efferents or exogenous nicotine), α7nAChR triggers multiple anti-inflammatory signaling cascades: (1) Jak2-Stat3 activation blocks NF-κB translocation, (2) prevents degradation of IκB (NF-κB inhibitor), (3) inhibits HMGB1 release (alarmin), (4) reduces pro-inflammatory cytokine transcription (TNF-α, IL-1β, IL-6, IL-18), (5) modulates calcium signaling to alter cellular activation state. This receptor is the molecular basis of the 'inflammatory reflex' by which the vagus nerve dampens peripheral inflammation.
α7nAChR is the key mechanism for parasympathetic anti-inflammatory effects, explaining why vagal tone, cholinergic herbs, and even nicotine patches can reduce inflammation. Therapeutic targeting (vagal stimulation, nicotine, cholinergic agonists) offers inflammation control without immunosuppression. Deficient acetylcholine availability (chronic stress, low choline) prevents receptor activation, contributing to uncontrolled inflammation.
- Requires 5 α7 subunits to form functional pentameric channel
- High calcium permeability when activated
- Expressed on macrophages, dendritic cells, microglia, T cells, B cells
- Nicotine binds with EC50 ~1.6 μM (lower concentrations than smoking produces)
- Activation reduces TNF-α production by 50-90% in stimulated macrophages
- Mediates both central (brain) and peripheral (immune) cholinergic effects
- Can be activated by acetylcholine, nicotine, choline, or synthetic agonists
- Receptor density decreases with chronic inflammation
- Acetylcholine — endogenous ligand activating the receptor
- Vagus nerve — vagal efferents release ACh to activate α7nAChR on immune cells
- Cholinergic anti-inflammatory pathway — α7nAChR is the molecular effector of this pathway
- Nicotine — exogenous agonist that activates receptor for anti-inflammatory effects
- Macrophages — express α7nAChR to receive vagal anti-inflammatory signals
- NF-κB — receptor activation blocks NF-κB nuclear translocation
- Jak2 — activated by receptor to initiate anti-inflammatory signaling
- STAT3 — Jak2 phosphorylates Stat3 to inhibit inflammatory gene expression
- TNF-α — production dramatically reduced by α7nAChR activation
- IL-6 — receptor activation suppresses IL-6 transcription
- IL-1β — α7nAChR blocks IL-1β production and release
- HMGB1 — receptor prevents release of this late inflammatory mediator
- Inflammation — receptor activation provides powerful anti-inflammatory effects
- Parasympathetic nervous system — mediates parasympathetic anti-inflammatory effects
- Choline — weak agonist at α7nAChR (requires higher concentrations)
- Sepsis — α7nAChR activation reduces mortality in sepsis models
- Inflammatory reflex — α7nAChR is the effector receptor in this reflex arc
- Endotoxemia — receptor activation protects against LPS-induced inflammation
- Cytokine storm — α7nAChR can dampen excessive cytokine production
- Oxidative phosphorylation — acetylcholine production requires OXPHOS to generate acetyl-CoA